Axonics raises $33M for its neuromodulation tech

Alfred Mann Foundation spinout Axonics Modulation Technologies raises nearly $33 million in a Series A round for its neuromodulation technology. Axonics Modulation Technologies said it drummed up a $32.6 million Series A round for the neuromodulation technology it's developing to treat chronic pain and overactive bladder. Irvine, Calif.-based Axonics said the round was led by Edmond de Rothschild Investment Partners and included NeoMed Management, Legend Capital and "a select group of private individuals." Axonics Modulation Technologies, Vessix Vascular Inc.News Well, Funding Roundup, Neuromodulation/Neurostimulation, Personnelread more
Source: Mass Device - Category: Medical Equipment Authors: Source Type: news